/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR
DISSEMINATION IN THE UNITED STATES/
MONTREAL, Feb. 20 /CNW Telbec/ - Ranaz Corporation ("Ranaz") (TSX-V: RNZ)
announces that it has completed the second and final tranche of its private
placement announced on January 30, 2009. Under this arm's length transaction,
Ranaz today delivered 896,449 shares and 2,460,129 share purchase warrants for
proceeds of about CA $121,000, which were held by a third party pending the
TSX Venture Exchange's decision on whether to allow the final closing of the
private placement. Each warrant entitles its holder to purchase one share for
$0.135 over a 24-month period. The proceeds of the private placement will be
used for general corporate purposes.
Ranaz has now issued a total of 4,920,258 shares and 2,460,129 warrants
pursuant to this private placement.
The common shares issued under the private placement are subject to a
four-month resale restriction ending on May 31, 2009, in accordance with the
applicable securities legislation and the policies of the TSX Venture
This press release does not constitute an offer to sell or a solicitation
of an offer to purchase securities, nor an offer, solicitation or sale in any
jurisdiction where such offer may be unlawful.
About Ranaz Corporation
Ranaz is a company specializing in the manufacture and marketing of
protein and dietary supplements. Its mission is to design, develop and market
nutritional, protein and dietary supplements under its own corporate brands
and concepts, such as Protidiet and ProtiLife, as well as under private
labels. For more information about the Company, please visit our website at
Certain statements contained in this news release, other than statements
of fact that are independently verifiable at the date hereof, may constitute
forward-looking statements. Such statements, based as they are on the current
expectations of management, inherently involve numerous risks and
uncertainties, known and unknown, many of which are beyond Ranaz's control.
Such risks include but are not limited to: the impact of general economic
conditions, changes in the regulatory environment in the jurisdictions in
which Ranaz does business, stock markets volatility, fluctuations in costs,
and changes to the competitive environment due to consolidation, as well as
other risks disclosed in public filings of Ranaz. Consequently, actual future
results may differ materially from the anticipated results expressed in the
forward-looking statements. The reader should not place undue reliance, if
any, on the forward-looking statements included in this news release. These
statements speak only as of the date made and Ranaz is under no obligation and
disavows any intention to update or revise such statements as a result of any
event, circumstances or otherwise.
The TSX Venture Exchange has not reviewed and does not accept
responsibility for the adequacy or accuracy of this release.
For further information:
For further information: Ranaz Corporation: Martin Vidal, Executive Vice
President and Chief Financial Officer, (450) 491-7106, Ext. 213,
firstname.lastname@example.org; SOLAK Communications: François Kalos, President,
(450) 993-0828, email@example.com